| Literature DB >> 10367897 |
A Avots1, M Buttmann, S Chuvpilo, C Escher, U Smola, A J Bannister, U R Rapp, T Kouzarides, E Serfling.
Abstract
NF-ATc, an inducibly expressed transcription factor, controls gene expression in T lymphocytes and cardiomyocytes. We show here that the transcriptional co-activators CBP/p300 bind to and control the activity of the inducible N-terminal transactivation domain of NF-ATc, TAD-A. Similar to the N terminal transactivation domain of c-Jun, TAD-A is inducibly phosphorylated, but this phosphorylation is dispensable for the interaction with CBP/p300. Constitutive active versions of c-Raf and Rac synergistically enhance the CBP/p300-mediated increase of TAD-A activity, indicating the important role CBP/p300 plays in the integration of T cell activation signals. Since a mutation of CBP abolishing HAT activity is almost as active as wild-type CBP in T cells, functions of CBP/p300 other than histone acetylation appear to control the NF-AT-dependent transcription in T cells.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10367897 DOI: 10.1016/s1074-7613(00)80051-5
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745